Atossa Therapeutics, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:ATOS) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 76.44 M70.75 M64.52 M58.01 M47.61 M37.94 M 負債合計 4.97 M5.42 M6.82 M8.22 M8.26 M7.46 M 純資産合計 71.48 M65.32 M57.7 M49.79 M39.35 M30.49 M 負債および純資産合計 76.44 M70.75 M64.52 M58.01 M47.61 M37.94 M 有利子負債合計 —————— 純負債 ——————

ニュース

Atossa Therapeutics, Inc. (ATOS) Discusses Challenges in Breast Cancer Drug Development and Innovation in Clinical Research Transcript

France stocks lower at close of trade; CAC 40 down 0.14%

France stocks lower at close of trade; CAC 40 down 0.67%

France stocks higher at close of trade; CAC 40 up 0.92%

France stocks lower at close of trade; CAC 40 down 0.87%

France stocks higher at close of trade; CAC 40 up 1.33%

France stocks higher at close of trade; CAC 40 up 0.31%

Atossa presents preclinical data on endoxifen for muscular dystrophy

France stocks lower at close of trade; CAC 40 down 0.19%

France stocks higher at close of trade; CAC 40 up 1.79%

France stocks lower at close of trade; CAC 40 down 0.65%

Atos 2025年度決算：売上高14%減も利益率は倍増